Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition. / Maddison, P.J.
Yn: Rheumatology, Cyfrol 41, Rhif 9, 01.09.2002, t. 965-971.
Yn: Rheumatology, Cyfrol 41, Rhif 9, 01.09.2002, t. 965-971.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Maddison, PJ 2002, 'Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.', Rheumatology, cyfrol. 41, rhif 9, tt. 965-971. https://doi.org/10.1093/rheumatology/41.9.965
APA
Maddison, P. J. (2002). Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition. Rheumatology, 41(9), 965-971. https://doi.org/10.1093/rheumatology/41.9.965
CBE
Maddison PJ. 2002. Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition. Rheumatology. 41(9):965-971. https://doi.org/10.1093/rheumatology/41.9.965
MLA
Maddison, P.J. "Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.". Rheumatology. 2002, 41(9). 965-971. https://doi.org/10.1093/rheumatology/41.9.965
VancouverVancouver
Maddison PJ. Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition. Rheumatology. 2002 Medi 1;41(9):965-971. doi: 10.1093/rheumatology/41.9.965
Author
RIS
TY - JOUR
T1 - Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.
AU - Maddison, P.J.
PY - 2002/9/1
Y1 - 2002/9/1
KW - RHEUMATOLOGY
U2 - 10.1093/rheumatology/41.9.965
DO - 10.1093/rheumatology/41.9.965
M3 - Article
VL - 41
SP - 965
EP - 971
JO - Rheumatology
JF - Rheumatology
SN - 1462-0324
IS - 9
ER -